Truist Financial Issues Positive Forecast for Molina Healthcare (NYSE:MOH) Stock Price

Molina Healthcare (NYSE:MOH) had its price target upped by equities researchers at Truist Financial from $205.00 to $250.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s target price suggests a potential upside of 4.35% from the company’s current price.

MOH has been the subject of several other reports. Royal Bank Of Canada boosted their price objective on Molina Healthcare from $216.00 to $248.00 and gave the stock a “sector perform” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $129.00 target price on shares of Molina Healthcare in a research report on Friday, April 24th. Zacks Research raised Molina Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Sanford C. Bernstein set a $286.00 price target on Molina Healthcare in a research report on Monday. Finally, Robert W. Baird increased their price target on Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Molina Healthcare has a consensus rating of “Hold” and a consensus target price of $197.31.

Molina Healthcare Trading Down 1.4%

Shares of NYSE:MOH opened at $239.58 on Tuesday. The company has a market cap of $12.48 billion, a PE ratio of 71.45 and a beta of 0.74. The company’s 50-day moving average price is $200.26 and its 200 day moving average price is $173.71. Molina Healthcare has a fifty-two week low of $121.06 and a fifty-two week high of $244.10. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same period in the previous year, the business posted $6.08 EPS. Molina Healthcare’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Sell-side analysts anticipate that Molina Healthcare will post 5.23 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer directly owned 12,815 shares in the company, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.44% of the company’s stock.

Hedge Funds Weigh In On Molina Healthcare

Several hedge funds have recently modified their holdings of MOH. AQR Capital Management LLC raised its stake in shares of Molina Healthcare by 217.0% in the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after buying an additional 2,008,458 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in Molina Healthcare by 10.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock valued at $376,831,000 after buying an additional 201,772 shares in the last quarter. Invesco Ltd. boosted its stake in Molina Healthcare by 24.2% during the fourth quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock valued at $293,453,000 after buying an additional 329,679 shares in the last quarter. Victory Capital Management Inc. grew its holdings in Molina Healthcare by 46.4% during the fourth quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock worth $244,796,000 after acquiring an additional 447,078 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in Molina Healthcare by 23.7% during the first quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company’s stock worth $185,929,000 after acquiring an additional 267,121 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.